R Rashaan, P T Arkoumanis, C Gakis, F A Lyssiotis, J Michalis, P Anagnostopoulos, K Stratakis
{"title":"肉毒杆菌毒素治疗复发性区域疼痛综合征的病例报告。","authors":"R Rashaan, P T Arkoumanis, C Gakis, F A Lyssiotis, J Michalis, P Anagnostopoulos, K Stratakis","doi":"10.26574/maedica.2024.19.1.182","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b>To evaluate subcutaneous Botulinum toxin type A (BTX-A) efficacy in alleviating severe allodynia in complex regional pain syndrome (CRPS) type II post-digit reconstruction. <b>Methods:</b> After surgical debridement and flap reconstruction for post-traumatic necrosis, a CRPS type II patient received subcutaneous BTX-A. Assessments tracked symptom changes and daily life improvements. <b>Discussion:</b>There are various CRPS management modalities, including rehabilitation and pharmacology. The limited efficacy of conventional non-steroidal antiinflammatory drugs contrasts with promising subcutaneous BTX-A, offering rapid pain relief. <b>Conclusion:</b>Our case underscores the efficacy of subcutaneous BTX-A in CRPS type II, prompting further research and safe outpatient protocol development.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079730/pdf/","citationCount":"0","resultStr":"{\"title\":\"Case Report on Botulinum Toxin Treatment for Complex Regional Pain Syndrome in a Digit Reconstruction.\",\"authors\":\"R Rashaan, P T Arkoumanis, C Gakis, F A Lyssiotis, J Michalis, P Anagnostopoulos, K Stratakis\",\"doi\":\"10.26574/maedica.2024.19.1.182\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objective:</b>To evaluate subcutaneous Botulinum toxin type A (BTX-A) efficacy in alleviating severe allodynia in complex regional pain syndrome (CRPS) type II post-digit reconstruction. <b>Methods:</b> After surgical debridement and flap reconstruction for post-traumatic necrosis, a CRPS type II patient received subcutaneous BTX-A. Assessments tracked symptom changes and daily life improvements. <b>Discussion:</b>There are various CRPS management modalities, including rehabilitation and pharmacology. The limited efficacy of conventional non-steroidal antiinflammatory drugs contrasts with promising subcutaneous BTX-A, offering rapid pain relief. <b>Conclusion:</b>Our case underscores the efficacy of subcutaneous BTX-A in CRPS type II, prompting further research and safe outpatient protocol development.</p>\",\"PeriodicalId\":74094,\"journal\":{\"name\":\"Maedica\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079730/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Maedica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26574/maedica.2024.19.1.182\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Maedica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26574/maedica.2024.19.1.182","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:评估皮下注射A型肉毒杆菌毒素(BTX-A)对缓解复杂性区域疼痛综合征(CRPS)II型趾骨重建术后严重异感症的疗效。治疗方法一名 II 型 CRPS 患者在因创伤后坏死而进行手术清创和皮瓣重建后,接受了皮下 BTX-A。评估跟踪了症状变化和日常生活改善情况。讨论:CRPS的治疗方法多种多样,包括康复治疗和药物治疗。传统的非甾体抗炎药物疗效有限,而皮下注射BTX-A可迅速缓解疼痛,两者形成鲜明对比。结论:我们的病例强调了皮下BTX-A对CRPS II型的疗效,促使我们进一步开展研究并制定安全的门诊方案。
Case Report on Botulinum Toxin Treatment for Complex Regional Pain Syndrome in a Digit Reconstruction.
Objective:To evaluate subcutaneous Botulinum toxin type A (BTX-A) efficacy in alleviating severe allodynia in complex regional pain syndrome (CRPS) type II post-digit reconstruction. Methods: After surgical debridement and flap reconstruction for post-traumatic necrosis, a CRPS type II patient received subcutaneous BTX-A. Assessments tracked symptom changes and daily life improvements. Discussion:There are various CRPS management modalities, including rehabilitation and pharmacology. The limited efficacy of conventional non-steroidal antiinflammatory drugs contrasts with promising subcutaneous BTX-A, offering rapid pain relief. Conclusion:Our case underscores the efficacy of subcutaneous BTX-A in CRPS type II, prompting further research and safe outpatient protocol development.